Market Cap 13.94M
Revenue (ttm) 0.00
Net Income (ttm) -11.16M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 3,302,000
Avg Vol 4,382,056
Day's Range N/A - N/A
Shares Out 25.55M
Stochastic %K 13%
Beta -1.58
Analysts Strong Sell
Price Target $17.67

Company Profile

Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. Medicus Pharma Ltd. has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to M...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 610 540 7515
Address:
300 Conshohocken State Road, Suite 200, Conshohocken, United States
ChartChartist
ChartChartist Mar. 15 at 4:00 PM
$MDCX coming up. Low volume, hard selling looks done $SKYQ love those pumps but lets us know $AMPY blue sky soon $INDO see that wedge that formed? Ready to go again $AEHL omgomgomg. Look at this great setup. Put on top watchlist. Keep eye for any movement . Setup is ripe. Post rs
0 · Reply
neverknew
neverknew Mar. 15 at 3:44 PM
0 · Reply
KOWALSK1
KOWALSK1 Mar. 14 at 2:19 PM
Trade Setup $MDCX ✅️ DEEP BUY ZONE 0.47 to 0.43 ✋️ RISK BELOW 0.36 💲PT. 0.50 0.64 0.72 0.80 + UP 📈🚀 Follow for more 🙏😊
0 · Reply
Ron_Burn
Ron_Burn Mar. 13 at 5:33 PM
$MDCX she's moving on a Friday... typically this would be an AH gapper luring in more buyers for next week.
0 · Reply
2TrustHim
2TrustHim Mar. 13 at 3:04 PM
$MDCX Going Out Update How Meeting Went!!! Should Move Up Later!!!
0 · Reply
GABBYGIRL
GABBYGIRL Mar. 13 at 2:51 PM
$MDCX we should have a new pr soon
0 · Reply
MajorGainz7
MajorGainz7 Mar. 13 at 2:22 PM
$MDCX .55 Wow heating up break .64 we flyyyyy
0 · Reply
MajorGainz7
MajorGainz7 Mar. 13 at 2:19 PM
$MDCX reversal Going to break recent highs
0 · Reply
GABBYGIRL
GABBYGIRL Mar. 13 at 1:39 PM
$MDCX Do dd. Check out Zip Trader's recent in depth deep dive. They are better than good enough....phenomenal
1 · Reply
thebusthebus
thebusthebus Mar. 13 at 12:08 PM
$MDCX 🤞🤞🤞🤞🤞🤞
0 · Reply
Latest News on MDCX
Medicus Pharma on Bloomberg World

Feb 12, 2026, 7:30 AM EST - 4 weeks ago

Medicus Pharma on Bloomberg World


Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement

Dec 5, 2025, 3:20 PM EST - 3 months ago

Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement


Medicus Pharma Ltd. to Present at The Maxim Growth Summit 2025

Oct 13, 2025, 7:30 AM EDT - 5 months ago

Medicus Pharma Ltd. to Present at The Maxim Growth Summit 2025


Medicus Pharma Ltd. To Present at Brookline Capital Markets

Sep 24, 2025, 7:30 AM EDT - 6 months ago

Medicus Pharma Ltd. To Present at Brookline Capital Markets


Medicus Pharma Ltd. Completes Acquisition of Antev Limited

Sep 2, 2025, 7:30 AM EDT - 6 months ago

Medicus Pharma Ltd. Completes Acquisition of Antev Limited


ChartChartist
ChartChartist Mar. 15 at 4:00 PM
$MDCX coming up. Low volume, hard selling looks done $SKYQ love those pumps but lets us know $AMPY blue sky soon $INDO see that wedge that formed? Ready to go again $AEHL omgomgomg. Look at this great setup. Put on top watchlist. Keep eye for any movement . Setup is ripe. Post rs
0 · Reply
neverknew
neverknew Mar. 15 at 3:44 PM
0 · Reply
KOWALSK1
KOWALSK1 Mar. 14 at 2:19 PM
Trade Setup $MDCX ✅️ DEEP BUY ZONE 0.47 to 0.43 ✋️ RISK BELOW 0.36 💲PT. 0.50 0.64 0.72 0.80 + UP 📈🚀 Follow for more 🙏😊
0 · Reply
Ron_Burn
Ron_Burn Mar. 13 at 5:33 PM
$MDCX she's moving on a Friday... typically this would be an AH gapper luring in more buyers for next week.
0 · Reply
2TrustHim
2TrustHim Mar. 13 at 3:04 PM
$MDCX Going Out Update How Meeting Went!!! Should Move Up Later!!!
0 · Reply
GABBYGIRL
GABBYGIRL Mar. 13 at 2:51 PM
$MDCX we should have a new pr soon
0 · Reply
MajorGainz7
MajorGainz7 Mar. 13 at 2:22 PM
$MDCX .55 Wow heating up break .64 we flyyyyy
0 · Reply
MajorGainz7
MajorGainz7 Mar. 13 at 2:19 PM
$MDCX reversal Going to break recent highs
0 · Reply
GABBYGIRL
GABBYGIRL Mar. 13 at 1:39 PM
$MDCX Do dd. Check out Zip Trader's recent in depth deep dive. They are better than good enough....phenomenal
1 · Reply
thebusthebus
thebusthebus Mar. 13 at 12:08 PM
$MDCX 🤞🤞🤞🤞🤞🤞
0 · Reply
thebusthebus
thebusthebus Mar. 13 at 12:06 PM
$MDCX this is all he talks about since the phase 2 results.
0 · Reply
thebusthebus
thebusthebus Mar. 13 at 12:03 PM
$MDCX are the phase 2 results on skin jet good enough for them to get a strategic partner? I would love to get the thoughts from people that follow this.
1 · Reply
Bhaddar1
Bhaddar1 Mar. 13 at 9:59 AM
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 13 at 1:57 AM
$MDCX RSI: 30.64, MACD: -0.1948 Vol: 0.37, MA20: 1.02, MA50: 1.21 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
robertward
robertward Mar. 13 at 12:34 AM
$MDCX who out there is still pumped about this stock? I’ve done some research on it, but I’m curious what I might be missing so if you’ve got a really positive take on the stock if you don’t mind sharing, that would be great.
2 · Reply
B2iDigital
B2iDigital Mar. 13 at 12:11 AM
As Marketing Partner for the 38th Annual ROTH Capital Partners Conference, B2i Digital is spotlighting presenting company Medicus Pharma Ltd. ($MDCX). Medicus Pharma Ltd. (Nasdaq: MDCX) is a precision-guided biotech/life sciences company focused on accelerating the clinical development programs of novel and potentially disruptive therapeutics assets. Medicus is advancing SkinJect, which recently reported positive Phase 2 data in basal cell carcinoma, achieving 73% clinical clearance and 40% histological clearance in the 200-µg cohort at Day 57. The company is also developing Teverelix, a next-generation gonadotrophin-releasing hormone (GnRH) antagonist currently entering Phase 2b for cardiovascular high-risk advanced prostate cancer and for patients experiencing first acute urinary retention relapse (AURr) associated with enlarged prostate. Presenting company website: http://www.medicuspharma.com/ B2i Digital Featured Conference details: https://b2idigital.com/38th-annual-roth-conference The 38th Annual ROTH Conference is an invitation-only corporate access event connecting executive teams from roughly 500 growth companies with institutional investors and other market participants. The conference is held at The Ritz-Carlton Laguna Niguel in Dana Point, California, March 22 to 24, 2026. It is one of the largest small-cap investor conferences in the United States. Conference features include: • 1-on-1 and small group management-investor meetings • Analyst-selected fireside chats, industry keynotes, and panels • ROTH Consumer Private Company Day & Emerging Brand Showcase • Inaugural Engineering & Construction Day (NEW) • ROTH/CAF Charity Ride, Spin, Yoga, Pickleball & Golf (Sunday) • Networking receptions and live evening entertainment B2i Digital, The Capital Markets Matchmaker℠, will leverage its network of 1.5 million+ investors to help enhance visibility for presenting companies, aligned with our mantra, From Marketing to Meetings℠. Registration is required and subject to approval by ROTH: https://www.meetmax.com/sched/event_127123/conference_home.html Credit to the team at ROTH for hosting this premier event: Byron Roth, Aaron Gurewitz, Isabel Mattson-Pain, Nazan Akdeniz, Otilia Charo, Grace Deller, Amanda McAdams, Jason Wittes, Boobalan Pachaiyappan, Jonathan Aschoff, Harry Fong, James Antonopoulos, Ben Bowen, Kris Salinger, Russ Nudelman, Andrew Kellogg, Matthew Robinson, David Farina. David Shapiro and Joseph Azizo from B2i Digital will also be in attendance and look forward to seeing you there. ROTH is a relationship-driven investment bank focused on serving growth companies and their investors across capital raising, equity research, sales and trading, M&A advisory, and corporate access. For more information, visit www.roth.com. B2i Digital is not a broker-dealer or investment adviser. This is for general information only and is not an offer to buy or sell any security.
1 · Reply
Balkly
Balkly Mar. 12 at 6:02 PM
$MDCX I'm ALL IN. Just waiting. Tick tock.
0 · Reply
ApexBu11
ApexBu11 Mar. 12 at 4:22 PM
$DXST $MDCX $PATH $SPY it’s about to rip, just needs a little volume
0 · Reply
ApexBu11
ApexBu11 Mar. 12 at 4:21 PM
1 · Reply
Zackpedia
Zackpedia Mar. 12 at 3:30 PM
$MDCX Down to .46
0 · Reply
2TrustHim
2TrustHim Mar. 12 at 3:12 PM
$MDCX Super Busy!!! https://medicuspharma.com/investor-relations/press-releases/
0 · Reply
Ver13
Ver13 Mar. 12 at 5:36 AM
$MDCX diluted shares smh
0 · Reply